The broadly neutralizing human monoclonal antibodies (MAbs) 2F5 and 4E10, both targeting the highly conserved human immunodeficiency virus type 1 (HIV-1) envelope membrane proximal external region (MPER), are among the MAbs using the broadest heterologous neutralizing activity and are of considerable interest for HIV-1 vaccine development. neutralizing antibodies are very hardly ever made in HIV-1… Continue reading The broadly neutralizing human monoclonal antibodies (MAbs) 2F5 and 4E10, both